Merus announces FDA Orphan Drug Designation of Zenocutuzumab for the Treatment of Pancreatic Cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company […]
ORYX Gaming Launches with 888 Casino
TORONTO, July 27, 2020 (GLOBE NEWSWIRE) — ORYX Gaming, a Bragg Gaming Group company (TSXV: BRAG, OTC: BRGFF), has agreed […]
Lumina Gold Announces Filing of NI 43-101 PEA Technical Report
VANCOUVER, British Columbia, July 27, 2020 (GLOBE NEWSWIRE) — Lumina Gold Corp. (TSXV: LUM) (OTCQX: LMGDF) (the “Company” or “Lumina”) […]
ADT To Release Second Quarter 2020 Earnings On Wednesday, August 5, 2020
BOCA RATON, Fla., July 27, 2020 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) will release its second quarter 2020 financial […]
Harsco Releases 2019-2020 Environmental, Social & Governance Report
Key milestones achieved in the execution of the Company’s strategy to transform into global, single thesis environment services business – […]
CF Energy Launch Operation of Its First EV Battery Swap Station in Sanya City
TORONTO, July 27, 2020 (GLOBE NEWSWIRE) — CF Energy Corp. (TSX-V: CFY) (“CF Energy” or the “Company”, together with its […]
Western Uranium & Vanadium Corp. Prevails in Permit Hearing
Toronto, Ontario and Nucla, Colorado, July 27, 2020 (GLOBE NEWSWIRE) — Western Uranium & Vanadium Corp. (CSE:WUC) (OTCQX:WSTRF) (“Western” or […]
Lithium Americas Provides Update on COVID-19 Response at Caucharí-Olaroz
VANCOUVER, British Columbia, July 27, 2020 (GLOBE NEWSWIRE) — Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the […]
OptimizeRx Joins with Change Healthcare to Expand Nationwide Platform Reach
ROCHESTER, Mich., July 27, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for […]
Checkpoint Therapeutics to Present Cosibelimab Interim Results from Registration-Enabling Trial at ESMO Virtual Congress 2020
Presentation to highlight updated interim data from global trial in patients with metastatic cutaneous squamous cell carcinomaOver 50% of enrollment […]
